FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Court Rules 12-Year-Old’s Mother Cannot Read Her the Bible, Take Her to Church

Illinois man charged with arson after allegedly setting home ablaze on Thanksgiving

USCIS halts ‘all asylum decisions’ after DC shooting of National Guard members

Abbey Gate Gold Star father blisters Biden after Afghan national allegedly ambushes 2 National Guardsmen in DC

Northwestern to pay $75M in federal civil-rights deal after antisemitism probes

Utah death row inmate with dementia dies of natural causes 3 months after execution was halted

At least two reported victims with gunshot wounds at Valley Fair Mall in California on Black Friday: police

State Department ‘immediately’ halts all Afghan passport visas following deadly National Guard attack

Trump plans ‘full and complete pardon’ for former Honduran president convicted of drug trafficking

EXCLUSIVE: Stefanik steamrolls top conservative opponent; GOP leaders hand her commanding edge in NY primary

A look back at the biggest presidential Thanksgiving scandals, surprises

Erika Kirk Shares First Thanksgiving Message Since Her Husband’s Passing

Political turkeys of 2025: Blunders of 2025 that will never be pardoned by the public

Afghan withdrawal refugees had ‘free rein’ on US bases in 2021, sources said, leaving in Ubers untracked

USA Today’s Spin on National Guard Shooting Shows Why Legacy Outlets Are Dying

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”